CNTB · NASDAQ · Biotechnology

Connect Biopharma (ADR) (CNTB)

Develops rademikibart for asthma and COPD outside Greater China.

$1.09
vs last close−0.13 (−10.41%)

Something off on this page? Send us feedback.

Next report
Nov 11, 26
in 49 days
EPS estimate
−$0.27
Revenue estimate
$114.9K
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.06−$0.03−$0.03−$0.04−$0.27−$0.34−$0.27Pending
Estimate−$0.26−$0.26−$0.22−$0.03−$0.30−$0.29−$0.31−$0.27
Surprise+77.8%+89.9%+85.4%−29.7%+10.0%−17.2%+14.3%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$261.9K$48.0K$24.4K$2.7MPending
Estimate$20.9M$48.0K$21.3K$4.9K$538$743.3K$743.3K$114.9K
Surprise−98.7%+125.4%−96.7%+269.7%

HistoryUpcoming

Date / PeriodEstimateReportedSurprise
Dec 2027−$0.24
Sep 2027−$0.27
Jun 2027−$0.27
Mar 2027−$0.27
Dec 2026−$0.31
Nov 2026−$0.27
Aug 2026−$0.31−$0.27+14.3%
May 2026−$0.29−$0.34−17.2%
Mar 2026−$0.30−$0.27+10.0%
Nov 2025−$0.03−$0.04−29.7%
Aug 2025
May 2025
Mar 2025
Sep 2024
Apr 2024
Dec 2023−$1.07
Sep 2023
Apr 2023
Sep 2022
Apr 2022
Aug 2021
Mar 2021
Jun 2020
Dec 2019
Jun 2019

The latest year is open to everyone — the 15 quarters behind it read with an account.

Date / PeriodEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Dec 2027−$0.24$4.6M
Sep 2027−$0.27$0
Jun 2027−$0.27$402.7K
Mar 2027−$0.27$0
Dec 2026−$0.31$251.6K
Nov 11, 2026−$0.27$114.9K
Aug 12, 2026−$0.31−$0.27+14.3%$743.3K$2.7M+269.7%+9.0%
May 12, 2026−$0.29−$0.34−17.2%$743.3K$24.4K−96.7%+14.5%
Mar 31, 2026−$0.30−$0.27+10.0%$538−9.7%
Nov 12, 2025−$0.03−$0.04−29.7%$4.9K+5.9%
Aug 13, 2025
May 15, 2025
Mar 31, 2025
Sep 5, 2024
Apr 16, 2024
Dec 12, 2023−$1.07$150.2M
Sep 12, 2023
Apr 11, 2023
Sep 13, 2022
Apr 1, 2022
Aug 31, 2021
Mar 19, 2021
Jun 30, 2020
Dec 31, 2019
Jun 30, 2019

The latest year is open to everyone — the 15 quarters behind it read with an account.